Unum jumps as investors lean into 2026 EPS growth and $1B buyback
Unum Group shares jumped 4.42% to $74.14 as investors refocused on its 2026 capital-return and earnings-growth outlook. The insurer has guided to 8%–12% 2026 EPS growth alongside a $1 billion share repurchase plan and a 10% dividend increase, supporting a multiple-expansion narrative.
1. What’s moving the stock
Unum Group (UNM) is rising after sentiment shifted back toward its 2026 financial framework—an outlook centered on mid-to-high single-digit operating momentum, strong capital generation, and aggressive shareholder returns. The setup is reinforced by management’s plan to return essentially all free cash flow via buybacks and dividends, which can directly lift EPS and tighten the share count even without a major acceleration in premium growth. (seekingalpha.com)
2. The key numbers investors are re-pricing
The company has outlined 8%–12% EPS growth for 2026, paired with a $1 billion share repurchase plan and a 10% dividend increase—signals that capital levels are viewed as comfortably above internal targets and that management is prioritizing per-share value creation. In its Q4 2025 update, Unum also disclosed it repurchased 3.3 million shares for $252.5 million during the quarter and ended 2025 with about 440% RBC and roughly $2.34 billion of holding-company liquidity, underscoring balance-sheet flexibility. (seekingalpha.com)
3. Why this matters now (the “cleaner core” angle)
A major 2026 reporting change is also helping the equity story: Unum plans to exclude Closed Block results from adjusted operating income beginning in 2026, aiming to make core earnings trends easier to evaluate and less dominated by long-term care runoff dynamics. That reframing has become a central part of the market’s multiple-expansion debate—whether investors should value Unum more like a steadier benefits franchise rather than a legacy LTC story. (investors.unum.com)
4. What to watch next
The next checkpoint is whether operating performance supports the stabilization narrative—especially in group disability and international lines—while the company executes on repurchases at current price levels. Confirmation that benefit ratios and claims trends are behaving in line with the 2026 framework, plus continued steady capital generation, would keep pressure on bears betting the stock’s valuation can’t expand from here. (investors.unum.com)